Galantamine vs Donepezil in the Treatment of Alzheimer’s Disease

被引：0
|
作者：
Barry Goldlist
Michael Gordon
Gary Naglie
机构：
[1] University of Toronto,Division of Geriatric Medicine
来源：
Drugs & Aging | 2003年 / 20卷
关键词：
Galantamine; Total Study Population; Negative Study; Small Pilot Study; Similar Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1139 / 1140
页数：1
相关论文
共 50 条
  • [21] PHARMACOLOGICAL ASPECTS OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Kim, Jae Kwang
    Park, Sang Un
    EXCLI JOURNAL, 2017, 16 : 35 - 39
  • [22] A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: A responder analysis
    Bullock, R
    Mahableshwarkar, AR
    Lilienfeld, S
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 250 - 251
  • [23] Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Tan, Chen-Chen
    Yu, Jin-Tai
    Wang, Hui-Fu
    Tan, Meng-Shan
    Meng, Xiang-Fei
    Wang, Chong
    Jiang, Teng
    Zhu, Xi-Chen
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 615 - 631
  • [24] Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer's disease receiving donepezil
    Kano, Osamu
    Ito, Hirono
    Takazawa, Takanori
    Kawase, Yuji
    Murata, Kiyoko
    Iwamoto, Konosuke
    Nagaoka, Tetsuro
    Hirayama, Takehisa
    Miura, Ken
    Nagata, Riya
    Kiyozuka, Tetsuhito
    Aoyagi, Jo
    Sato, Ryuta
    Eguchi, Teruo
    Ikeda, Ken
    Iwasaki, Yasuo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 259 - 265
  • [25] Galantamine for Alzheimer's disease
    Prvulovic, David
    Hampel, Harald
    Pantel, Johannes
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (03) : 345 - 354
  • [26] Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine
    Kurz, AF
    Gold, M
    NEUROBIOLOGY OF AGING, 2004, 25 : S202 - S203
  • [27] Donepezil/galantamine/rivastigminePisa syndrome in elderly patients with Alzheimer’s disease: 5 case reports
    Reactions Weekly, 2007, 1169 (1) : 14 - 14
  • [28] Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease - A systematic review
    Clegg, A
    Bryant, J
    Nicholson, T
    McIntyre, L
    De Broe, S
    Gerard, K
    Waugh, N
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (03) : 497 - 507
  • [29] The comparison with galantamine and donepezil on Alzheimer's Disease patients and its relationship with cerebral blood flow
    Wake, Rei
    Araki, Tomoko
    Miyaoka, Tsuyoshi
    Nagahama, Michiharu
    Liemoa, Erlyn
    Hashioka, Sadayuki
    Horiguchi, Jun
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 265 - 266
  • [30] A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMER'S DISEASE (AD)
    Feng, J.
    Huang, R.
    Pwee, K.
    VALUE IN HEALTH, 2010, 13 (07) : A560 - A560
12345